MORE LOBBYING FIREPOWER FOR AAM, BIO: The Association for Accessible Medicines, which represents generic drugmakers, is expanding its roster of hired guns, bringing on White House-linked Florida ...
A new law to combat the rising cost of generic drugs is now in effect across Connecticut. But the legislation, which is being challenged by a national organization representing drug distribution ...
Twitter, now X, co-founder Biz Stone and Pinterest co-founder Evan Sharp have already helped create mainstream social networks. Now the pair are teaming up to create a new app called Tangle, which ...
Did our AI summary help? As New Year 2026 approaches, artificial intelligence tools are increasingly being used to create personalised wishes, greetings, images, and short messages for friends, family ...
A new sodium-ion battery offers a cheaper and safer alternative to conventional lithium-ion systems, scientists say, paving the way for more sustainable EVs. When you purchase through links on our ...
More than 280 new billionaires were minted this year, made richer in part by rising stocks and a return of IPO activity. The U.S. led the global billionaire increase, with 92 new self-made ...
Sony is under fire after releasing a set of new free PSN avatars as part of the digital PlayStation Advent Calendar 2025. The PlayStation Advent Calendar is an annual online activity that, for reasons ...
New SEC rules could reshape the crypto ETF landscape by speeding up approvals, reducing the shutdown backlog and giving issuers a clearer and faster path to market. The SEC introduced new ...
Three Republican-led states have challenged the Food and Drug Administration’s (FDA) approval of a generic form of the abortion pill mifepristone earlier this year, arguing the agency’s decision had ...
(Reuters) -Three Republican-led states have moved to broaden their lawsuit seeking to restrict access to the abortion pill mifepristone, aiming to block the U.S. Food and Drug Administration's recent ...
Missouri Attorney General Catherine Hanaway is asking a federal court to roll back the U.S. Food and Drug Administration’s recent decision to approve a new generic brand of mifepristone, her first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results